Literature DB >> 17688193

Expression of heat shock proteins in myocardium of patients with atrial fibrillation.

Miao Yang1, Hao Tan, Longxian Cheng, Meian He, Qingyi Wei, Robert M Tanguay, Tangchun Wu.   

Abstract

Atrial fibrillation (AF) is the most common sustained arrhythmia. Because heat shock proteins (Hsp) can protect cells from stress, we compared the levels of Hsp60, Hsp72, Hsc73, and Hsp27 in atrial myocardium from 17 patients with AF (8 paroxysmal and 9 persistent) and 7 controls in sinus rhythm (SR). Hsp60, Hsp72, and Hsc73 levels were not significantly different among the 3 groups. Hsp27 expression was slightly higher in paroxysmal AF than in SR and in persistent AF, and a borderline significant difference (P = 0.064) was seen between the paroxysmal and persistent AF subgroups. Hsp60 levels in the moderate, severe, and profound myolysis groups were significantly lower than the light myolysis group, but no differences were found in other Hsps. In summary, the data indicate that expression of Hsp27 and Hsc73 may be associated with different stages of AF and that Hsp60 also may be associated with the degree of atrial myolysis.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17688193      PMCID: PMC1949328          DOI: 10.1379/csc-253r.1

Source DB:  PubMed          Journal:  Cell Stress Chaperones        ISSN: 1355-8145            Impact factor:   3.667


  39 in total

Review 1.  Molecular chaperones in the cytosol: from nascent chain to folded protein.

Authors:  F Ulrich Hartl; Manajit Hayer-Hartl
Journal:  Science       Date:  2002-03-08       Impact factor: 47.728

Review 2.  Heat shock proteins, inflammation, and cardiovascular disease.

Authors:  A Graham Pockley
Journal:  Circulation       Date:  2002-02-26       Impact factor: 29.690

Review 3.  Molecular chaperones--cellular machines for protein folding.

Authors:  Stefan Walter; Johannes Buchner
Journal:  Angew Chem Int Ed Engl       Date:  2002-04-02       Impact factor: 15.336

4.  Time course of atrial fibrillation-induced cellular structural remodeling in atria of the goat.

Authors:  J Ausma; N Litjens; M H Lenders; H Duimel; F Mast; L Wouters; F Ramaekers; M Allessie; M Borgers
Journal:  J Mol Cell Cardiol       Date:  2001-12       Impact factor: 5.000

Review 5.  Role of heat shock proteins in atherosclerosis.

Authors:  Qingbo Xu
Journal:  Arterioscler Thromb Vasc Biol       Date:  2002-10-01       Impact factor: 8.311

Review 6.  Invited review: Interplay between molecular chaperones and signaling pathways in survival of heat shock.

Authors:  Vladimir L Gabai; Michael Y Sherman
Journal:  J Appl Physiol (1985)       Date:  2002-04

7.  Overexpression of heat shock protein 60/10 in myocardium of patients with chronic atrial fibrillation.

Authors:  Alfons E Schäfler; Kiriakos Kirmanoglou; Peter Pecher; Andreas Hannekum; Bernd Schumacher
Journal:  Ann Thorac Surg       Date:  2002-09       Impact factor: 4.330

Review 8.  Electrical, contractile and structural remodeling during atrial fibrillation.

Authors:  Maurits Allessie; Jannie Ausma; Ulrich Schotten
Journal:  Cardiovasc Res       Date:  2002-05       Impact factor: 10.787

9.  The expression of heat shock protein 60 in myocardium of patients with chronic atrial fibrillation.

Authors:  Alfons E Schäfler; Kiriakos Kirmanoglou; Jochen Balbach; Peter Pecher; Andreas Hannekum; Bernd Schumacher
Journal:  Basic Res Cardiol       Date:  2002-05       Impact factor: 17.165

Review 10.  Chaperoning signaling pathways: molecular chaperones as stress-sensing 'heat shock' proteins.

Authors:  Ellen A A Nollen; Richard I Morimoto
Journal:  J Cell Sci       Date:  2002-07-15       Impact factor: 5.235

View more
  22 in total

Review 1.  Inflammasomes and Proteostasis Novel Molecular Mechanisms Associated With Atrial Fibrillation.

Authors:  Na Li; Bianca J J M Brundel
Journal:  Circ Res       Date:  2020-06-18       Impact factor: 17.367

2.  Effect of corticosteroids on atrial fibrillation after catheter ablation: a meta-analysis.

Authors:  Sanjay Jaiswal; Xian-Bao Liu; Qu-Cheng Wei; Ying-Hao Sun; Li-Han Wang; Liu-Guang Song; Dan-Dan Yang; Jian-An Wang
Journal:  J Zhejiang Univ Sci B       Date:  2018 Jan.       Impact factor: 3.066

3.  Characterization of hsp27 kinases activated by elevated aortic pressure in heart.

Authors:  Benoit Boivin; Maya Khairallah; Raymond Cartier; Bruce G Allen
Journal:  Mol Cell Biochem       Date:  2012-08-10       Impact factor: 3.396

Review 4.  Heat shock protein expression during cardiac surgery.

Authors:  Ahmad Z Chaudhry; Michael D Diodato; Malek G Massad
Journal:  World J Surg       Date:  2010-04       Impact factor: 3.352

Review 5.  Inflammation and the pathogenesis of atrial fibrillation.

Authors:  Yu-Feng Hu; Yi-Jen Chen; Yenn-Jiang Lin; Shih-Ann Chen
Journal:  Nat Rev Cardiol       Date:  2015-01-27       Impact factor: 32.419

Review 6.  Small heat shock proteins in redox metabolism: implications for cardiovascular diseases.

Authors:  Elisabeth S Christians; Takahiro Ishiwata; Ivor J Benjamin
Journal:  Int J Biochem Cell Biol       Date:  2012-06-15       Impact factor: 5.085

7.  Decreased Cardiac Expression of Heat Shock Protein 27 is Associated with Atrial Fibrillation in Patients with Rheumatic Heart Disease.

Authors:  Wei Wu; Zhibing Lu; Yuanhong Li; Zhiqiang Chen; Hong Jiang; Yan Li
Journal:  Acta Cardiol Sin       Date:  2015-01       Impact factor: 2.672

8.  Meta-analysis of Transcriptomic Data Reveals Pathophysiological Modules Involved with Atrial Fibrillation.

Authors:  Rodrigo Haas Bueno; Mariana Recamonde-Mendoza
Journal:  Mol Diagn Ther       Date:  2020-10-23       Impact factor: 4.074

9.  The protective effect of heat shock protein 70 (Hsp70) in atrial fibrillation in various cardiomyopathy conditions.

Authors:  Too Jae Min; Won-Min Jo; Seung Yong Shin; Hong Euy Lim
Journal:  Heart Vessels       Date:  2014-06-03       Impact factor: 2.037

Review 10.  Beat shock proteins and atrial fibrillation.

Authors:  Harm H Kampinga; Robert H Henning; Isabelle C van Gelder; Bianca J J M Brundel
Journal:  Cell Stress Chaperones       Date:  2007       Impact factor: 3.667

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.